Inicio 5 News 5 10 months of life expectancy makes a difference in ALS

10 months of life expectancy makes a difference in ALS

11 Sep, 2022

Amylyx Pharmaceuticals Inc’s (AMLX.O) drug for amyotrophic lateral sclerosis (ALS) won support from outside advisers to the US Food and Drug Administration on Wednesday, months after the panel rejected it over issues with the test data. ALS, the cause of which is largely unknown, destroys nerve cells in the brain and spinal cord. It affects more than 31,000 patients in the United States, according to 2017 CDC data.

“ALS is fast-moving, 100% deadly, and has no meaningful treatment…a drug that extends life, whether it’s 6, 10, or 18 months, has shown more than enough evidence of efficacy,” said Ben Wallace, 41. years, who was diagnosed with ALS in 2018

Last News

Últimas noticias

Approved new vaccine for Respiratory Syncytial Virus (RSV)

The European Commission has approved 'Beyfortus' (nirsevimab) for the prevention of lower respiratory tract infection caused by respiratory syncytial virus (RSV) in newborns and infants during their first RSV season. RSV is a common and highly contagious seasonal...

First Gene Therapy for Hemophilia B

Earlier this week, the etranacogene dezaparvovec (Hemgenix) made history as the first gene therapy approved by the US Food and Drug Administration (FDA) for the treatment of the rare genetic disorder hemophilia B. Patients with hemophilia B lack the ability to make a...

6 Supplements People Often Take to Lower “Bad” Cholesterol

Some people believe that dietary supplements such as fish oil, garlic, cinnamon, turmeric, plant sterols, and red yeast rice will lower their "bad" cholesterol. "Bad" cholesterol, known in the medical community as low-density lipoprotein, or LDL, can cause fatty...